Moderna Chief Human Resources Officer Tracey Franklin has expanded her role to Chief People and Digital Technology Officer, overseeing the Company's talent and digital functions. Brad Miller, Chief ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

Netflix is starting to pick up the pace of its original movies again as 2024 winds down. The problem is that not all of them deserve to be counted among the very best. Netflix has always favored ...

While 2024 has been a quiet year by the standards of Netflix’s programming, October has an embarrassment of riches when it comes to original series. Nobody Wants This has been a breakout hit ...

The study, published in ACS Nano, analysed more than 150 blood samples taken from 19 people in the 28 days after they received the Moderna SPIKEVAX mRNA booster. It also uncovered another key ...

Of course, Crunchyroll is still the king but Netflix has been slowly picking up lots of various series and movies to bolster their original lineup. Most of Netflix’s anime series and movies aren’t ...

The Netflix Original library is now a key component of the total Netflix library list. We’ve got the complete list of Netflix Originals listed below plus expanded genres too so you can browse and ...

According to Reuters, the company earned $6.7 billion in revenue from Spikevax in 2023. Moderna has stated in the past that it is “not aware of any significant intellectual property impediments ...

Find out what’s happening with Jamie Lee Curtis, Kyle Richards, and more "Halloween" stars since their first run-in with Michael Myers.

According to the lawsuit, the development of Moderna’s COVID-19 vaccine, Spikevax, depended on key technological advancements made at Northwestern. Also Read: Alnylam’s Concedes Its Patent ...

The lawsuit said, opens new tab Moderna uses Northwestern-developed lipid nanoparticle (LNP) technology without a license in Spikevax shots to transport fragile messenger RNA into the human body.

Moderna earned US$6.7 billion (S$8.7 billion) in revenue from Spikevax last year. Pfizer made US$11.2 billion from sales of Comirnaty, the Covid vaccine it developed with German partner BioNTech.